Clinical trials
Breast Neoplasms trials in Vietnam
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
24 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2004 | 1 |
| 2006 | 1 |
| 2008 | 1 |
| 2012 | 1 |
| 2013 | 1 |
| 2016 | 1 |
| 2019 | 2 |
| 2020 | 2 |
| 2022 | 2 |
| 2023 | 4 |
| 2024 | 4 |
| 2025 | 3 |
| 2026 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 10 |
| Recruiting | 8 |
| Active, not recruiting | 3 |
| Unknown status | 2 |
| Enrolling by invitation | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| AstraZeneca | 6 |
| Gene Solutions | 4 |
| Novartis Pharmaceuticals | 3 |
| International Breast Cancer Research Foundation | 2 |
| Merck Sharp & Dohme LLC | 2 |
| Boston University | 1 |
| Gia Dinh People Hospital | 1 |
| Hoffmann-La Roche | 1 |
| MetiMedi Pharmaceuticals | 1 |
| Nanogen Pharmaceutical Biotechnology Joint Stock Company | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Breast Neoplasms | 24 |
| Lung Neoplasms | 4 |
| Stomach Neoplasms | 4 |
| Colorectal Neoplasms | 3 |
| Triple Negative Breast Neoplasms | 3 |
| Carcinoma, Hepatocellular | 2 |
| Liver Neoplasms | 2 |
| Neoplasm Metastasis | 2 |
| Pancreatic Neoplasms | 2 |
| Carcinoma, Non-Small-Cell Lung | 1 |
Trials
Showing 76 to 24 of 24. Each trial links to its page on Pharma Observatory.
No trials match these filters.
Try a different keyword, or clear a filter.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.